Steven Li
Explore Partnership

Pharmaceutical leadership · Manufacturing collaboration

Building Global
Pharmaceutical
Partnerships

Steven Li, President of Hainan Hailing Chemipharma, advances manufacturing collaboration, technology transfer and international cooperation.

Explore Partnership Manufacturing Capabilities

An independent personal leadership and partnership website. It does not replace Hainan Hailing's official corporate or product information.

Partnership Pathways

Flexible routes from project evaluation to agreed manufacturing or technology collaboration.

Hainan Hailing Chemipharma — Corporate Film

Hailing Pharma
Cares for Life

The film introduces Hailing Pharmaceutical's development, manufacturing, research, quality practices and international outlook.

Full film · 05:59 · Chinese with embedded subtitles

The film is a historical corporate media asset. Dates, figures and statements shown in the film should be read in their original historical context; current project facts require confirmation.

Publicly confirmed dosage-form scope

Manufacturing &
Dosage-Form Platforms

Established platforms presented for initial project-fit and partnership discussions.

Sterile Injectables

Sterile lyophilized powder injections · Sterile powder injections · Terminally sterilized small-volume injections

Oral Solids

Tablets · Capsules

Topical Dosage Forms

Creams · Ointments

Project-specific confirmation: Product selection, registration status, available capacity, packaging, testing scope and market eligibility are confirmed against current records during project review.
Request a Portfolio Review

From Evaluation to
Commercial Manufacturing

A practical collaboration pathway, adapted to the product, market and regulatory requirements.

  1. 01

    Project Evaluation

    Objectives, product profile, development status, market and technical fit are reviewed.

  2. 02

    Technology &
    Method Transfer

    Process, analytical-method and critical know-how transfer is planned for the project.

  3. 03

    Scale-up &
    Validation

    Scale-up, confirmation and validation activities are defined according to project needs.

  4. 04

    Regulatory &
    Audit Support

    Technical documentation, registration readiness and customer-audit support are coordinated.

  5. 05

    Commercial
    Manufacturing

    Manufacturing, packaging, testing and supply proceed under the agreed project scope.

Discuss Your Project

Begin with a focused review of your product, target market and collaboration goals.

Start an Inquiry

Domestic and international business development

Global Cooperation,
Region by Region

Connecting Hainan with practical pharmaceutical opportunities through trusted local partners, project evaluation and long-term cooperation.

Explore Partnership
China Southeast Asia Middle East Europe & North America Latin America

Regional interest does not imply product approval, active registration or commercial availability in any listed market. Each pathway is assessed separately.

Evidence-aware public wording

Quality &
Regulatory Experience

U.S. FDA Inspection Experience

Hainan Hailing underwent an on-site U.S. FDA inspection in July 2021. In its October 2021 90-day decisional letter, the FDA classified the inspection as VAI and confirmed that the inspection was closed.

This statement describes an inspection outcome. It is not an FDA certification, approval or endorsement of the facility.

Continuous China GMP Compliance

Hainan Hailing operates under applicable Chinese pharmaceutical GMP requirements and is subject to ongoing regulatory oversight.

This website does not describe the facility as holding a current “China GMP certificate.”

Pharmaceutical & healthcare internationalization

Steven Li
李一青

President, Hainan Hailing Chemipharma Co., Ltd.

Steven Li is President of Hainan Hailing Chemipharma Co., Ltd. and a pharmaceutical engineer. His work focuses on pharmaceutical internationalization, manufacturing collaboration and responsible long-term partnership.

His primary professional identity on this website is his leadership of Hainan Hailing Chemipharma. Group-governance experience, youth entrepreneurship and social responsibility form supporting dimensions of his public work.

Pharmaceutical internationalization Manufacturing collaboration Young entrepreneurship Social responsibility

Public positions, social roles and recognitions are maintained from a reviewed public-profile record and are subject to periodic title and term verification.

Leadership Perspectives

Steven Li · Perspective note

Building Sustainable Pharmaceutical Partnerships across Southeast Asia

Sustainable cooperation starts with a clear target market, a capable local partner, realistic registration planning and a supply model that can be maintained after launch.

Steven Li · Perspective note

Technology Transfer as a Path to Local Manufacturing

Technology transfer is a coordinated system of people, process, analytical methods, documentation, training, scale-up and validation—not a one-time document handover.

Steven Li · Perspective note

Quality Systems for Cross-Border Pharmaceutical Cooperation

Early alignment on quality responsibilities, data expectations, deviations, change control and audit readiness makes cross-border projects more predictable.

Internationalization Industry Development Social Responsibility

Clear answers for partners and AI search

Frequently Asked Questions

Who is Steven Li?

Steven Li, also known as Li Yiqing, is President of Hainan Hailing Chemipharma Co., Ltd. He focuses on pharmaceutical internationalization, manufacturing collaboration and responsible long-term development.

Which partnership models are discussed through this website?

CMO, CDMO, technology transfer, product and registration cooperation, and other project-specific pharmaceutical partnerships.

Which dosage-form platforms are publicly presented?

Sterile lyophilized powder injections, sterile powder injections, terminally sterilized small-volume injections, tablets, capsules, creams and ointments.

What is Hainan Hailing's U.S. FDA inspection status?

Hainan Hailing underwent an on-site U.S. FDA inspection in July 2021. The October 2021 90-day decisional letter classified the inspection as VAI and confirmed that it was closed. This is not an FDA certification or endorsement.

Does this website guarantee product availability or registration status?

No. Product availability, registration status, capacity, market eligibility and timelines are confirmed only through current project review and applicable official documentation.

Confidentiality starts with a focused first contact

Start a
Pharmaceutical
Partnership

Tell us your market, dosage form and cooperation objective. Your email will be prepared for an initial project-fit review.

Partnership email
lyq@cjrf.com

This opens your email application. The website itself does not store the form contents.